APA (7th ed.) Citation

Grimm, M., Schostak, M., Grün, B., Loidl, W., Pichler, M., Zimmermann, U., . . . Meran, J. (2024). Nivolumab + Ipilimumab as immunotherapeutic boost in metastatic urothelial carcinoma: A nonrandomized clinical trial. JAMA oncology, 10(6), . https://doi.org/10.1001/jamaoncol.2024.0938

Chicago Style (17th ed.) Citation

Grimm, Marc-Oliver, et al. "Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial." JAMA Oncology 10, no. 6 (2024). https://doi.org/10.1001/jamaoncol.2024.0938.

MLA (9th ed.) Citation

Grimm, Marc-Oliver, et al. "Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial." JAMA Oncology, vol. 10, no. 6, 2024, https://doi.org/10.1001/jamaoncol.2024.0938.